Prostate cancer: 2. Natural history.
作者信息
Nam R K, Jewett M A, Krahn M D
机构信息
Department of Surgery, University of Toronto, Ont.
出版信息
CMAJ. 1998 Sep 22;159(6):685-91.
Abstract
摘要
相似文献
1
Prostate cancer: 2. Natural history.
CMAJ. 1998 Sep 22;159(6):685-91.
2
The management of localized prostate cancer.
Br J Hosp Med. 1996;55(5):232-3.
3
Natural history and staging of prostate cancer.
Urol Clin North Am. 1984 May;11(2):205-20.
4
Adenocarcinoma of the prostate.
Compr Ther. 1978 Aug;4(8):18-26.
5
More about prostate cancer--expectant management versus treatment.
N C Med J. 1999 Nov-Dec;60(6):313-4.
6
[Prostatic carcinoma: histoprognosis, prognostic value of Gleason's index].
Bull Cancer. 1985;72(5):414-22.
7
Adenocarcinoma of the prostate: an overview.
Urol Clin North Am. 1980 Oct;7(3):579-81.
8
9
Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
Scand J Urol Nephrol. 2006;40(4):265-71. doi: 10.1080/00365590600750110.
10
[Prostatic adenocarcinoma: pathological stage C. I: Diagnosis, technical aspects and significance].
J Urol (Paris). 1991;97(1):5-9.
引用本文的文献
1
The role of bisphosphonates in the management of prostate cancer.
Curr Oncol Rep. 2006 May;8(3):221-7. doi: 10.1007/s11912-006-0023-7.
2
Radical prostatectomy as treatment for prostate cancer.
CMAJ. 2003 Jan 7;168(1):44-5.
3
PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.
CMAJ. 2000 Mar 21;162(6):789-90.
4
Understanding obesity.
CMAJ. 1999 Jun 29;160(13):1821.
5
Understanding obesity.
CMAJ. 1999 Jun 29;160(13):1820-1.
6
The more the better?
CMAJ. 1999 Jun 29;160(13):1820.
7
Prostate cancer from a patient's perspective.
CMAJ. 1999 Jun 29;160(13):1820.
8
Prostate cancer: 6. Surgical treatment of localized disease.
CMAJ. 1998 Nov 17;159(10):1265-71.
本文引用的文献
1
Prostate specific antigen velocity as a measure of the natural history of prostate cancer: defining a 'rapid riser' subset.
Br J Urol. 1998 Jan;81(1):100-4. doi: 10.1046/j.1464-410x.1998.00523.x.
2
Primer on medical decision analysis: Part 4--Analyzing the model and interpreting the results.
Med Decis Making. 1997 Apr-Jun;17(2):142-51. doi: 10.1177/0272989X9701700204.
3
Population-based study of long-term survival in patients with clinically localised prostate cancer.
Lancet. 1997 Mar 29;349(9056):906-10. doi: 10.1016/S0140-6736(96)09380-4.
4
Smoking and fatal prostate cancer in a large cohort of adult men.
Am J Epidemiol. 1997 Mar 1;145(5):466-75. doi: 10.1093/oxfordjournals.aje.a009129.
5
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden.
JAMA. 1997 Feb 12;277(6):467-71.
6
Results of radical prostatectomy in men with clinically localized prostate cancer.
JAMA. 1996 Aug 28;276(8):615-9.
7
Prospective study of sex hormone levels and risk of prostate cancer.
J Natl Cancer Inst. 1996 Aug 21;88(16):1118-26. doi: 10.1093/jnci/88.16.1118.
8
Carcinoma of the prostate: results of radical radiotherapy (1970-1985).
Int J Radiat Oncol Biol Phys. 1993 May 20;26(2):203-10. doi: 10.1016/0360-3016(93)90198-5.
9
Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer.
CA Cancer J Clin. 1993 Mar-Apr;43(2):83-91. doi: 10.3322/canjclin.43.2.83.
10
Results of conservative management of clinically localized prostate cancer.
N Engl J Med. 1994 Jan 27;330(4):242-8. doi: 10.1056/NEJM199401273300403.
Zotero 插件